Company lists · Data refreshed September 2026
Top 25 Immunotherapy venture capital companies based in France
RevenueBase identified 65 immunotherapy venture capital companies headquartered in France as of September 2026 and tracks 967 professional contacts across them, including 457 with verified work emails and 44 with mobile numbers. Paris is the largest hub.
This list covers immunotherapy venture capital companies headquartered in France, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, how directly it supports the match, and when it was last checked. Data refreshed September 3, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase SmartSearch, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest immunotherapy venture capital companies based in France
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | TransgenePartial evidence | 207 | |||
“Cancer immunotherapy Transgene (Euronext: TNG) is a clinical-stage biotechnology company focused on individualized therapeutic vaccines” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 2 | OSE ImmunotherapeuticsPartial evidence | 92 | |||
“OSE Immunotherapeutics, a biotech dedicated to developing first-in-class assets in immuno-oncology (IO) & immuno-inflammation (I&I).” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 3 | 77 | ||||
“Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 4 | 47 | ||||
“Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 5 | 42 | ||||
“Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 6 | Smart ImmuneIndirect evidence | 24 | |||
“Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 7 | XenotheraIndirect evidence | 23 | |||
“XENOTHERA is a biotechnology company based 21 rue La Nouë Bras de Fer, Nantes, France.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 8 | Mnemo TherapeuticsPartial evidence | 22 | |||
“Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 9 | 21 | ||||
“Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 10 | InotremPartial evidence | 20 | |||
“Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 11 | 18 | ||||
“Neovacs, a French Biotechnology company, develops therapeutic vaccines for the treatment of autoimmune, inflammatory diseases aand invests in innovative companies (Biotech and…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 12 | 18 | ||||
“Invectys, Inc.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 13 | 17 | ||||
“Apmonia Therapeutics is a clinical-stage biotechnology company developing innovative peptide therapeutics designed to target the tumor microenvironment and improve outcomes for…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 14 | PeptinovIndirect evidence | 11 | |||
“Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 15 | 10 | ||||
“AdBio Partners is a venture capital firm dedicated to transforming breakthrough science into patient-ready therapies.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 16 | 10 | ||||
“Tridek-One is a spin-off from Inserm that develops first-in-class therapeutic agonistic monoclonal antibodies targeting immune checkpoint inhibitory receptors for the treatment of…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 17 | 10 | ||||
“Mise au point en Immunologie et Cancérologie de médicaments innovants à potentiel curatif.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 18 | 9 | ||||
“Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 19 | SteminovIndirect evidence | 8 | |||
“StemInov is a French Drug Discovery company working on a innovative cell based therapy in immunology” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 20 | 7 | ||||
“Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 21 | OlgramIndirect evidence | 7 | |||
“Traumatic brain injury is the #1 cause of death in people under 30.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 22 | 7 | ||||
“Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 23 | Odimma TherapeuticsPartial evidence | 7 | |||
“Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 24 | Starkage TherapeuticsIndirect evidence | 6 | |||
“StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 25 | 6 | ||||
“Altevax is a Phase 2 clinical-stage biotechnology company developing a pioneering melanin-based immunotherapy platform for cancer treatment.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
Showing 25 of 65 immunotherapy venture capital companies based in France
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 457 reachable decision-makers.
Free signup · no credit card
Immunotherapy venture capital companies based in France at a glance
As of Sep 3, 2026Companies by employee count
Verified emails by last verification
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and evidence rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase SmartSearch, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in France whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
- What we exclude
- Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside France are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and an evidence rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 457 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Frequently asked
How many immunotherapy venture capital companies are there based in France?
RevenueBase identified 65 immunotherapy venture capital companies headquartered in France as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Transgene, headquartered in Illkirch-Graffenstaden, tops this list with the largest team on record.
Which city has the most immunotherapy venture capital companies?
Paris leads with 23 headquartered companies, followed by Marseille (3) and Montpellier (3).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 457 verified decision-maker contacts tracked across these 65 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.
Ready to reach these companies? Verified emails and direct dials for all 65 immunotherapy venture capital companies based in France. Start with a free account, no credit card.
Get the full listRelated lists
Immunotherapy venture capital companies by geography
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
- Immunotherapy venture capital companies based in Spain
- Immunotherapy venture capital companies based in Boston, United States
- Immunotherapy venture capital companies based in Cambridge, United States
- Immunotherapy venture capital companies based in New York, United States
- Immunotherapy venture capital companies based in San Diego, United States
- Immunotherapy venture capital companies based in San Francisco, United States
Browse the directory
Browse: Companies home · All France lists · All Immunotherapy venture capital companies lists · New lists
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase SmartSearch, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia